MAVILIO, Fulvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.889
AS - Asia 9.390
EU - Europa 7.342
SA - Sud America 1.249
AF - Africa 202
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 9
Totale 37.119
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.581
SG - Singapore 4.029
GB - Regno Unito 2.120
CN - Cina 1.915
HK - Hong Kong 1.325
IT - Italia 1.046
BR - Brasile 994
RU - Federazione Russa 984
VN - Vietnam 820
SE - Svezia 741
FI - Finlandia 650
DE - Germania 527
FR - Francia 324
UA - Ucraina 273
KR - Corea 236
BG - Bulgaria 220
TR - Turchia 210
IN - India 157
CA - Canada 147
ID - Indonesia 125
BD - Bangladesh 102
MX - Messico 95
NL - Olanda 95
AR - Argentina 92
JP - Giappone 89
IQ - Iraq 71
IE - Irlanda 60
AE - Emirati Arabi Uniti 53
ZA - Sudafrica 53
BE - Belgio 46
EC - Ecuador 43
PL - Polonia 40
AU - Australia 35
ES - Italia 35
CO - Colombia 32
MA - Marocco 32
UZ - Uzbekistan 32
EG - Egitto 31
AT - Austria 30
PK - Pakistan 30
VE - Venezuela 29
CL - Cile 24
PH - Filippine 22
LT - Lituania 19
SA - Arabia Saudita 19
SI - Slovenia 19
TN - Tunisia 19
BZ - Belize 17
MY - Malesia 17
TH - Thailandia 15
CH - Svizzera 14
KE - Kenya 14
AZ - Azerbaigian 13
DZ - Algeria 13
IR - Iran 13
BO - Bolivia 12
CZ - Repubblica Ceca 12
DK - Danimarca 12
JO - Giordania 11
NP - Nepal 11
CR - Costa Rica 10
KZ - Kazakistan 10
LU - Lussemburgo 10
RO - Romania 10
TW - Taiwan 10
GR - Grecia 9
PT - Portogallo 9
PY - Paraguay 9
PA - Panama 8
PE - Perù 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
IL - Israele 7
OM - Oman 7
BY - Bielorussia 6
MD - Moldavia 6
UY - Uruguay 6
CI - Costa d'Avorio 5
NG - Nigeria 5
NI - Nicaragua 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
EU - Europa 4
HU - Ungheria 4
JM - Giamaica 4
PS - Palestinian Territory 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
CY - Cipro 3
GE - Georgia 3
GH - Ghana 3
GT - Guatemala 3
KG - Kirghizistan 3
Totale 37.072
Salva come PNG Salva come JPEG
Città #
Singapore 2.935
Fairfield 2.045
Santa Clara 1.902
Ashburn 1.889
Hong Kong 1.304
Southend 1.212
Woodbridge 1.088
Chandler 952
Houston 937
San Jose 727
Wilmington 669
Seattle 657
Cambridge 626
Ann Arbor 596
Helsinki 562
London 554
Jacksonville 503
Nyköping 455
Beijing 435
Hefei 402
Dearborn 387
Chicago 320
The Dalles 316
Los Angeles 309
San Diego 273
Council Bluffs 248
Modena 243
Ho Chi Minh City 240
Seoul 225
Princeton 221
Sofia 214
Hanoi 182
Salt Lake City 138
New York 135
Buffalo 122
Bremen 119
Milan 107
Eugene 102
Shanghai 93
Jakarta 91
Lauterbourg 89
Moscow 88
Elk Grove Village 77
Izmir 75
São Paulo 75
Des Moines 64
Dallas 63
Dublin 60
Tampa 57
Dong Ket 52
Frankfurt am Main 52
Tokyo 46
Brussels 43
Da Nang 43
San Francisco 41
Atlanta 39
Redwood City 38
Redondo Beach 37
Rio de Janeiro 36
Columbus 35
Norwalk 35
Guangzhou 34
Vancouver 34
Belo Horizonte 33
Haiphong 33
Boardman 32
Burlington 31
Phoenix 31
Baghdad 29
Bonndorf 29
Lancaster 29
Mexico City 29
Brooklyn 28
Nuremberg 28
Toronto 28
Delft 27
Falls Church 27
Munich 27
Paris 27
Rome 27
Hounslow 26
Orem 26
Sterling 26
Tashkent 25
Warsaw 25
Cairo 22
Dhaka 22
Kilburn 22
Montreal 22
Chennai 20
Denver 20
Melbourne 20
Brasília 19
Johannesburg 19
Nanjing 18
Belize City 17
Dulles 17
Hangzhou 17
Biên Hòa 16
Brantford 16
Totale 26.658
Salva come PNG Salva come JPEG
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 898
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 408
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 407
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 395
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 393
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 390
Mechanisms of retroviral integration and mutagenesis 363
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 363
Comprehensive genomic access to vector integration in clinical gene therapy 356
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 350
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 350
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 329
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 327
Site-specific integration by the adeno-associated virus rep protein 322
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 314
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 313
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 312
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 311
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 310
Medicina rigenerativa e nuove frontiere terapeutiche 310
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 310
A single epidermal stem cell strategy for safe ex vivo gene therapy 309
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 299
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 299
Nuclear architecture dictates HIV-1 integration site selection 297
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 293
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 287
Tracking gene-modified T cells in vivo. 286
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 286
Site-specific integration into the human genome: Ready for clinical application? 285
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 285
Gene therapy approaches for epidermolysis bullosa 284
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 280
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 277
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 271
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 270
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 268
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 267
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 264
Gene therapy of skin adhesion disorders (mini review) 264
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 263
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 261
Stem cell plasticity: time for a reappraisal? 259
Muscle-derived hematopoietic stem cells are hematopoietic in origin 259
Defining the lentiviral integrome in human hematopoietic cells 258
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 254
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 252
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 252
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 250
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 247
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 247
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 246
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 245
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 245
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 244
Gene therapy of inherited skin adhesion disorders: a critical overview 241
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 240
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 240
Towards a gene therapy clinical trial for epidermolysis bullosa 238
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 238
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 236
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 235
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 234
Interactions between Retroviruses and the Host Cell Genome 233
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 230
Clonal analysis of stably transduced human epidermal stem cells in culture. 224
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 222
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 218
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 216
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 214
The future of gene therapy 213
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 212
Safety of retroviral gene marking with a truncated NGF receptor 212
Toward gene therapy of junctional epidermolysis bullosa (JEB) 211
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 208
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 207
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 205
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 205
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 203
Gene therapies need new development models 201
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 201
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 200
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 197
Repairing without cutting: A safer alternative to gene correction? 195
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 195
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 192
Epithelial stem cells in corneal regeneration and epidermal gene therapy 192
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 190
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 189
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene 188
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 186
A human homoeo box gene specifically expressed in spinal cord during embryonic development 183
Perspectives on Best Practices for Gene Therapy Programs 182
Designing lentiviral vectors for gene therapy of genetic diseases 180
A novel homeo-domain protein, prep 1, forms a regulatory complex with pbx proteins in vivo 177
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 176
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 175
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 175
Two human homeobox genes, c1 and c8: Structure analysis and expression in embryonic development 169
Gene therapy: back on track? 162
Totale 26.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.816
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021961 0 0 0 0 0 0 0 0 0 439 314 208
2021/20223.677 389 358 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20256.512 187 55 68 494 1.324 934 338 365 789 471 710 777
2025/202611.986 701 445 866 1.380 2.794 945 1.691 696 1.292 1.176 0 0
Totale 37.451